annb0t
Top 20
- Renewal reaffirms longstanding, public-private partnership between Seqirus and the Biomedical Advanced Research and Development Authority (BARDA) to strengthen preparedness and rapid response capabilities for influenza pandemics
- Agreement includes provision for Seqirus to provide BARDA with supply of AUDENZ, the first-ever FDA-approved adjuvanted, cell-based pandemic influenza vaccine, which was developed in partnership with BARDA
SUMMIT, N.J., Feb. 25, 2022 /PRNewswire/ --
Seqirus, a glo...
>>> Read more: Seqirus and U.S. Government Renew Multi-Year Agreement for Influenza Pandemic Preparedness and Response
- Agreement includes provision for Seqirus to provide BARDA with supply of AUDENZ, the first-ever FDA-approved adjuvanted, cell-based pandemic influenza vaccine, which was developed in partnership with BARDA
SUMMIT, N.J., Feb. 25, 2022 /PRNewswire/ --
Seqirus, a glo...
>>> Read more: Seqirus and U.S. Government Renew Multi-Year Agreement for Influenza Pandemic Preparedness and Response
